PAM
IOVA icon

Panagora Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Panagora Asset Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-214,997
Closed -$1.59M – 1147
2024
Q4 		$1.59M Sell
214,997
-77,098
-26% -$715K 0.01% 563
2024
Q3 		$2.74M Sell
292,095
-69,092
-19% -$655K 0.01% 476
2024
Q2 		$2.9M Buy
361,187
+37,521
+12% +$402K 0.01% 430
2024
Q1 		$4.8M Sell
323,666
-22,524
-7% -$262K 0.03% 348
2023
Q4 		$2.81M Buy
346,190
+12,216
+4% +$63.9K 0.02% 464
2023
Q3 		$1.52M Sell
333,974
-56,120
-14% -$366K 0.01% 626
2023
Q2 		$2.75M Buy
390,094
+296,053
+315% +$2.12M 0.02% 459
2023
Q1 		$575K Buy
+94,041
New +$649K ﹤0.01% 1068
2021
Q3 		– Sell
-3,336
Closed -$87K – 2038
2021
Q2 		$87K Hold
3,336
– – ﹤0.01% 1939
2021
Q1 		$106K Buy
+3,336
New +$138K ﹤0.01% 1989
2016
Q1 		– Sell
-977
Closed -$7K – 2314
2015
Q4 		$7K Sell
977
-10,265
-91% -$71.2K ﹤0.01% 2232
2015
Q3 		$63K Buy
11,242
+6,494
+137% +$50.6K ﹤0.01% 1935
2015
Q2 		$41K Buy
+4,748
New +$53K ﹤0.01% 2183

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Panagora Asset Management's IOVA Position: Q1 2025 in Review

Panagora Asset Management sold out of Iovance Biotherapeutics (IOVA) in Q1 2025, closing a stake of 214,997 shares — an estimated $1.59M sold.

Panagora Asset Management first reported a position in IOVA in Q2 2015 and held it in 13 quarters. The position peaked at $4.8M in Q1 2024. 302 funds tracked by Wall St. Rank hold IOVA as of Q1 2025.

  • Panagora Asset Management reported no remaining Iovance Biotherapeutics position as of Q1 2025 after selling out during the quarter.
  • Panagora Asset Management sold 214,997 Iovance Biotherapeutics shares in Q1 2025, an estimated $1.59M.
  • Panagora Asset Management first reported a position in Iovance Biotherapeutics in Q2 2015 and held it in 13 quarters.
  • Panagora Asset Management's Iovance Biotherapeutics position peaked at $4.8M in Q1 2024.
  • 302 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2025.

Based on Panagora Asset Management's 13F filing for Q1 2025, filed 15 May 2025.